Androgenetic alopecia

Androgenetic alopecia is undoubtedly the most common form of hair loss. Although the condition is so frequent that it is sometimes considered a physiologic sign of aging, it causes considerable discomfort to patients and has been proven to impair their quality of life.1,2 This paper briefly reports the updated knowledge about the pathogenesis of androgenetic alopecia and reviews diagnosis and treatment of this condition.

[1]  J. Shapiro,et al.  Hair regrowth. Therapeutic agents. , 1998, Dermatologic clinics.

[2]  A. Barrera.  Micrograft and minigraft megasession hair transplantation results after a single session. , 1997, Plastic and reconstructive surgery.

[3]  M. Sawaya,et al.  Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. , 1997, The Journal of investigative dermatology.

[4]  A. Tosti,et al.  Diffuse hypertrichosis during treatment with 5% topical minoxidil , 1997, The British journal of dermatology.

[5]  W. Unger.  What's new in hair replacement surgery. , 1996, Dermatologic clinics.

[6]  F. Klopp.  Guidelines of care for androgenetic alopecia , 1996 .

[7]  K. Kaufman,et al.  Androgen metabolism as it affects hair growth in androgenetic alopecia. , 1996, Dermatologic clinics.

[8]  W. James,et al.  Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride. , 1995, Archives of dermatology.

[9]  R. Happle,et al.  Immunohistochemical evidence for differential distribution of 5α‐reductase isoenzymes in human skin , 1995, The British journal of dermatology.

[10]  N. Sadick,et al.  The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness. , 1994, The Journal of clinical endocrinology and metabolism.

[11]  M. Warner,et al.  Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution. , 1994, Archives of dermatology.

[12]  T. F. Cash,et al.  Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. , 1993, Journal of the American Academy of Dermatology.

[13]  T. F. Cash,et al.  The psychological effects of androgenetic alopecia in men. , 1992, Journal of the American Academy of Dermatology.

[14]  M. Brunden,et al.  Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. , 1992, The Journal of clinical endocrinology and metabolism.

[15]  E. DeLong,et al.  Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. , 1990, Journal of the American Academy of Dermatology.

[16]  A. Dunaif,et al.  The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia. , 1988, Journal of the American Academy of Dermatology.

[17]  R. Devillez.  Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection. , 1987, Dermatologica.

[18]  R. Happle,et al.  The inheritance of common baldness: two B or not two B? , 1984, Journal of the American Academy of Dermatology.

[19]  C. Mortimer,et al.  Effective medical treatment for common baldness in women , 1984, Clinical and experimental dermatology.

[20]  H. Baden,et al.  Effect of minoxidil on cultured keratinocytes. , 1983, The Journal of investigative dermatology.

[21]  E. Ludwig.  Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex , 1977, The British journal of dermatology.

[22]  F. C. Tring.  Disorders of hair growth. , 1976, Nursing times.

[23]  O. Norwood,et al.  Male Pattern Baldness: classification and Incidence , 1975, Southern medical journal.

[24]  I. I. Lubowe.  Hair growth and hair regeneration , 1959 .

[25]  J. Hamilton.  PATTERNED LOSS OF HAIR IN MAN: TYPES AND INCIDENCE , 1951, Annals of the New York Academy of Sciences.